CHEN; Bingliang

Patent Applications and Registrations

Patent applications and USPTO patent grants for CHEN; Bingliang.The latest application filed is for "novel bispecific antibody molecule and bispecific antibody simultaneously binding to pd-l1 and lag-3".

Company Profile

9.19.26

CHEN; Bingliang - Suzhou Jiangsu
Chen; Bingliang - Jiangsu CN
CHEN; Bingliang - Alameda CA
Chen; Bingliang - Milpitas CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Bispecific Antibody Molecule And Bispecific Antibody Simultaneously Binding To Pd-l1 And Lag-3 App 20220112284 - NI; Haiqing ; et al.	2022-04-14
Anti-CD47 antibodies and uses thereof Grant 11,292,836 - Tsun , et al. April 5, 2	2022-04-05
Combination Therapy Using An Anti-fucosyl-gm1 Antibody And An Anti-cd137 Antibody App 20210363267 - CARDARELLI; Josephine M. ; et al.	2021-11-25
Combination therapy using an anti-fucosyl-GM1 antibody and an anti-CD137 antibody Grant 11,104,739 - Cardarelli , et al. August 31, 2	2021-08-31
Anti-cd47 Antibody And Use Thereof App 20200377593 - LIU; Dandan ; et al.	2020-12-03
Anti-pd-l1 Antibody And Uses Thereof App 20200332009 - Miao; Xiaoniu ; et al.	2020-10-22
Anti-cd47 Antibodies And Uses Thereof App 20200181259 - TSUN; Andy ; et al.	2020-06-11
Anti-ox40 Antibody And Use Thereof App 20200140562 - Tsun; Andy ; et al.	2020-05-07
Monoclonal Antibodies to Programmed Death 1 (PD-1) App 20200138945 - Korman; Alan J. ; et al.	2020-05-07
Monoclonal antibodies to programmed death 1 (PD-1) Grant 10,441,655 - Korman , et al. Oc	2019-10-15
Combination Therapy Using An Anti-fucosyl-gm1 Antibody And An Anti-cd137 Antibody App 20190119395 - CARDARELLI; Josephine M. ; et al.	2019-04-25
Monoclonal Antibodies to Programmed Death 1 (PD-1) App 20170088615 - KORMAN; Alan J. ; et al.	2017-03-30
Methods for treating cancer using anti-PD-1 antibodies Grant 9,492,540 - Korman , et al. November 15, 2	2016-11-15
Monoclonal antibodies to Programmed Death 1 (PD-1) Grant 9,492,539 - Korman , et al. November 15, 2	2016-11-15
Monoclonal antibodies to programmed death 1 (PD-1) Grant 9,387,247 - Korman , et al. July 12, 2	2016-07-12
Methods for treating cancer using anti-PD-1 antibodies in combination with anti-CTLA-4 antibodies Grant 9,358,289 - Korman , et al. June 7, 2	2016-06-07
Methods for treating cancer using anti-PD-1 antibodies Grant 9,084,776 - Korman , et al. July 21, 2	2015-07-21
Methods For Treating Cancer Using Anti-pd-1 Antibodies App 20150165025 - KORMAN; Alan J. ; et al.	2015-06-18
Monoclonal Antibodies To Programmed Death 1 (pd-1) App 20140348743 - Korman; Alan J. ; et al.	2014-11-27
Methods For Treating Cancer Using Anti-pd-1 Antibodies App 20140328833 - Korman; Alan J. ; et al.	2014-11-06
Monoclonal Antibodies To Programmed Death 1 (pd-1) App 20140294852 - Korman; Alan J. ; et al.	2014-10-02
Methods For Treating Cancer Using Anti-pd-1 Antibodies In Combination With Anti-ctla-4 Antibodies App 20140212422 - Korman; Alan J. ; et al.	2014-07-31
Monoclonal antibodies against stromal derived factor-1 (SDF-1) Grant 8,496,931 - Pogue , et al. July 30, 2	2013-07-30
Human Antibodies That Bind Mesothelin, And Uses Thereof App 20130190481 - TERRETT; JONATHAN A. ; et al.	2013-07-25
Fully Human Antibodies Specific To Cadm1 App 20130156788 - TERRETT; Jonathan Alexander ; et al.	2013-06-20
Human antibodies that bind mesothelin, and uses thereof Grant 8,425,904 - Terrett , et al. April 23, 2	2013-04-23
Fully human antibodies specific to CADM1 Grant 8,420,084 - Terrett , et al. April 16, 2	2013-04-16
Human antibodies that bind mesothelin, and uses thereof Grant 8,399,623 - Terrett , et al. March 19, 2	2013-03-19
Human antibodies that bind mesothelin, and uses thereof Grant 8,383,779 - Terrett , et al. February 26, 2	2013-02-26
Human Antibodies That Bind Mesothelin, And Uses Thereof App 20130028906 - Terrett; Jonathan A. ; et al.	2013-01-31
Human Antibodies That Bind Mesothelin, And Uses Thereof App 20130028904 - Terrett; Jonathan A. ; et al.	2013-01-31
Human Antibodies That Bind Mesothelin, And Uses Thereof App 20130028905 - Terrett; Jonathan A. ; et al.	2013-01-31
Human antibodies that bind mesothelin, and uses thereof Grant 8,268,970 - Terrett , et al. September 18, 2	2012-09-18
Fully Human Antibodies Specific To Cadm1 App 20120093826 - Terrett; Jonathan Alexander ; et al.	2012-04-19
Human Antibodies That Bind Mesothelin, And Uses Thereof App 20110262448 - TERRETT; Jonathan A. ; et al.	2011-10-27
Anti-b7h4 Monoclonal Antibody-drug Conjugate And Methods Of Use App 20110085970 - Terrett; Jonathan A. ; et al.	2011-04-14
Monoclonal Antibodies Against Stromal Derived Factor-1 (sdf-1) App 20100158902 - Pogue; Sarah L. ; et al.	2010-06-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.